[go: up one dir, main page]

UY33097A - DERIVADOS DE (1h-PIRAZOL-5-IL)UREIDOARILO 1,3-DISUSTITUIDOS Y SUS USOS TERAPÉUTICOS - Google Patents

DERIVADOS DE (1h-PIRAZOL-5-IL)UREIDOARILO 1,3-DISUSTITUIDOS Y SUS USOS TERAPÉUTICOS

Info

Publication number
UY33097A
UY33097A UY0001033097A UY33097A UY33097A UY 33097 A UY33097 A UY 33097A UY 0001033097 A UY0001033097 A UY 0001033097A UY 33097 A UY33097 A UY 33097A UY 33097 A UY33097 A UY 33097A
Authority
UY
Uruguay
Prior art keywords
ureidoarilo
disustituidos
pirazol
derivatives
therapeutic uses
Prior art date
Application number
UY0001033097A
Other languages
English (en)
Spanish (es)
Inventor
King-Underwood John
Ito Kasuhiro
Strong Peter
Rapeport William Garth
Catherine Charron
Murray Peter John
Williams Jonathan Gareth
Onions Stuart Thomas
Robert Fenton
Original Assignee
Respivert Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Respivert Ltd filed Critical Respivert Ltd
Publication of UY33097A publication Critical patent/UY33097A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
UY0001033097A 2009-12-11 2010-12-10 DERIVADOS DE (1h-PIRAZOL-5-IL)UREIDOARILO 1,3-DISUSTITUIDOS Y SUS USOS TERAPÉUTICOS UY33097A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0921731.6A GB0921731D0 (en) 2009-12-11 2009-12-11 Theraputic uses

Publications (1)

Publication Number Publication Date
UY33097A true UY33097A (es) 2011-06-30

Family

ID=41666983

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001033097A UY33097A (es) 2009-12-11 2010-12-10 DERIVADOS DE (1h-PIRAZOL-5-IL)UREIDOARILO 1,3-DISUSTITUIDOS Y SUS USOS TERAPÉUTICOS

Country Status (4)

Country Link
GB (1) GB0921731D0 (fr)
TW (1) TW201130813A (fr)
UY (1) UY33097A (fr)
WO (1) WO2011070368A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0821227A2 (pt) 2007-12-19 2015-06-16 Cancer Rec Tech Ltd Composto, composição farmacêutica, método para preparar a mesma, uso de um composto, método para tratar uma doença ou distúrbio, para inibir função de raf e para inibir proliferação celular, inibir progressão do ciclo celular, promover apoptose, ou uma combinação de um ou mais dos mesmos
GB0905955D0 (en) 2009-04-06 2009-05-20 Respivert Ltd Novel compounds
EP2531502B1 (fr) 2010-02-01 2014-04-02 Cancer Research Technology Limited 1-(5-tert-butyl-2-phényl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-méthyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phényl]-urée et composés associés, et leur utilisation dans des traitements
EP2582700B1 (fr) 2010-06-17 2016-11-02 Respivert Limited Formulations respiratoires contenant inhibiteurs de p38 mapk
GB201010196D0 (en) * 2010-06-17 2010-07-21 Respivert Ltd Methods
GB201010193D0 (en) * 2010-06-17 2010-07-21 Respivert Ltd Medicinal use
PL2763984T3 (pl) 2011-10-03 2016-10-31 1-pirazolilo-3-(4-((2-anilinopirymidyno-4-ilo)oksy)naftaleno-1-ilo)moczniki jako inhibitory kinazy p38 MAP
EP2578582A1 (fr) 2011-10-03 2013-04-10 Respivert Limited 1-Pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napthtalèn-1-yl) urées comme inhibiteurs de la p38 MAP kinase
PE20141370A1 (es) 2011-12-09 2014-10-17 Chiesi Farma Spa Inhibidores de quinasa
CA2860479A1 (fr) 2011-12-09 2013-06-13 Chiesi Farmaceutici S.P.A. Inhibiteurs de kinases
GB201214750D0 (en) 2012-08-17 2012-10-03 Respivert Ltd Compounds
GB201215357D0 (en) 2012-08-29 2012-10-10 Respivert Ltd Compounds
WO2014033449A1 (fr) 2012-08-29 2014-03-06 Respivert Limited Inhibiteurs de kinases
US20150225373A1 (en) 2012-08-29 2015-08-13 Respivert Limited Kinase inhibitors
EP2890460B1 (fr) 2012-08-29 2017-02-22 Respivert Limited Inhibiteurs de kinases
EP2925742B1 (fr) 2012-11-16 2016-10-26 Respivert Limited Inhibiteurs de kinase
WO2014140582A1 (fr) 2013-03-14 2014-09-18 Respivert Limited Inhibiteurs de kinases
EP2981535B8 (fr) 2013-04-02 2021-03-10 Oxular Acquisitions Limited Dérivés d'urée utilisés en tant qu'inhibiteurs de kinase
WO2014162121A1 (fr) 2013-04-02 2014-10-09 Topivert Pharma Limited Inhibiteurs de kinase à base de n-alkyl pyrazoles
GB201320729D0 (en) 2013-11-25 2014-01-08 Cancer Rec Tech Ltd Therapeutic compounds and their use
GB201320732D0 (en) 2013-11-25 2014-01-08 Cancer Rec Tech Ltd Methods of chemical synthesis
EP3083604A1 (fr) 2013-12-20 2016-10-26 Respivert Limited Dérivés d'urée utiles comme inhibiteurs de kinase
JP6586098B2 (ja) 2014-02-14 2019-10-02 レスピバート・リミテツド キナーゼ阻害剤としてのピラゾリル尿素
MA40774A (fr) 2014-10-01 2017-08-08 Respivert Ltd Dérivés de diaryle-urée en tant qu'inhibiteurs de kinase p38
BR112018067552A2 (pt) 2016-04-06 2019-01-08 Topivert Pharma Ltd inibidores de cinase

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA73492C2 (en) 1999-01-19 2005-08-15 Aromatic heterocyclic compounds as antiinflammatory agents
WO2003072569A1 (fr) * 2002-02-25 2003-09-04 Boehringer Ingelheim Pharmaceuticals, Inc. Composes de cycloalkyle uree benzofusionnes a disubstitution en position 1,4 utiles dans le traitement de maladies mediees par la cytokine
MX2007016311A (es) 2005-06-20 2008-03-07 Tibotec Pharm Ltd Bencimidazoles sustituidos con heterociclilaminoalquilo.
ATE539748T1 (de) 2006-01-27 2012-01-15 Array Biopharma Inc Glucokinaseaktivatoren
AU2007208156A1 (en) 2006-01-30 2007-08-02 Irm Llc Spiro imidazole derivatives as PPAR modulators
WO2007096764A2 (fr) 2006-02-27 2007-08-30 Glenmark Pharmaceuticals S.A. Dérivés d'hétéroaryles bicycliques en tant que modulateurs des récepteurs cannabinoïdes
EP2370428B1 (fr) * 2008-12-11 2016-08-10 Respivert Limited Inhibiteur de kinase map p38

Also Published As

Publication number Publication date
GB0921731D0 (en) 2010-01-27
TW201130813A (en) 2011-09-16
WO2011070368A1 (fr) 2011-06-16

Similar Documents

Publication Publication Date Title
UY33097A (es) DERIVADOS DE (1h-PIRAZOL-5-IL)UREIDOARILO 1,3-DISUSTITUIDOS Y SUS USOS TERAPÉUTICOS
ECSP17084267A (es) Pirazolo[1,5—a]pirimidinas como agentes antivirales
ECSP11011310A (es) Análogos carba - nucleósido para tratamiento antiviral
CL2019000271A1 (es) Inhibidores de polimerasa hcv. (divisional solicitud 201600493)
UA116083C2 (uk) Похідні пурину для лікування вірусних інфекцій
CL2017001426A1 (es) Nuevos compuestos de 5-amino-6h-tiazolo[4,5-d]pirimidin-2,7-diona 3-sustituidos para el tratamiento y profilaxis de infecciones virales.
ECSP10010210A (es) Compuestos nucleósidos antivirales
CA2807584C (fr) Analogues de carba-nucleosides substitues par 2'-fluoro pour traitement antiviral
ECSP099319A (es) Analogos de tiofeno para el tratamiento o prevencion de las infecciones por flavivirus
CO6561783A2 (es) Inhibidores del virus flaviviridae
PH12015500347A1 (en) 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
ECSP12011684A (es) Inhibidores de los virus flaviviridae.
CY1117200T1 (el) Παραγωγα βενζυλαμινης ως αναστολεις καλλικρεϊνης πλασματος
MX346264B (es) Compuestos antivirales.
ECSP10010609A (es) Carba-nucleosidos analogos 1' - sustituidos para tratamiento antiviral
NZ629996A (en) 2’- substituted carba-nucleoside analogs for antiviral treatment
IN2012DN01855A (fr)
ECSP11011389A (es) Compuestos orgánicos y sus usos
MX2012006026A (es) Derivados de acido 5-alquinil-tiofen-2-carboxilico y usos para tratamiento o prevencion de infecciones por flavivirus.
ECSP15035530A (es) Compuestos tetracíclicos sustituidos con heterociclo y métodos de uso de los mismos para el tratamiento de enfermedades víricas
MX2016001855A (es) Nuevos aza-oxo-indoles para el tratamiento y profilaxis de la infeccion por virus sincitial respiratorio.
CY1118399T1 (el) Ενωσεις βενζοφουρανιου για την θεραπεια μολυνσεων ιου ηπατιτιδας c
CL2008002291A1 (es) Compuestos derivados del acido 4-fluor-benzoico, inhibidores de la polimerasa hcv, composicion farmaceutica, kit farmaceutico y su uso para el tratamiento de una infeccion viral por hepatitis c.
ECSP13013075A (es) Método de tratamiento de la fiebre dengue
UY30545A1 (es) Derivados sustituidos del acido acilamino-benzoico, composiciones que los contienen y aplicaciones